Effect of quinolones on intestinal ecology

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 65-70

  Edlund, Charlotta ^a,b   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENOXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RUFLOXACIN; SITAFLOXACIN; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; CONFERENCE PAPER; ENTEROBACTERIACEAE; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM POSITIVE BACTERIUM; HUMAN; INTESTINE FLORA; NONHUMAN;

BACTERIA (MICROORGANISMS); ENTEROBACTERIA; ENTEROBACTERIACEAE; NEGIBACTERIA; POSIBACTERIA;

EID: 0032755473     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00013     Document Type: Conference Paper

References (27)

1. Brumfitt W, Franklin I, Grady D, et al. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother 1984; 26: 757-61
2. Rozenberg-Arska M, Dekker AW, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis 1985; 152: 104-7
3. Enzenberger R, Shah PM, Knothe H. Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection 1985; 13: 273-5
4. Bergan T, Delin C, Johansen S, et al. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother 1986; 29: 298-302
5. Van Saene JJM, Van Saene HKF, Geitz JN, et al. Quinolones and colonization resistance in human volunteers. Pharm Weekbl Sci 1986; 8: 67-71
6. Holt HA, Lewis DA, White LO, et al. Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. Eur J Clin Microbiol 1986; 5: 201-5
7. Esposito S, Barba D, Galante D, et al. Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy. Drugs Exp Clin Res 1987; 10: 641-6
8. Ljungberg B, Nilsson-Ehle I, Edlund C, et al. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption. Scand J Infect Dis 1990; 22: 205-8
9. Brismar B, Edlund C, Malmborg AS, et al. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1990; 34: 481-3
10. Wiström J, Gentry LO, Palmgren AC, et al. Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea. J Antimicrob Chemother 1992; 30: 693-706
11. Edlund C, Lidbeck A, Kager L, et al. Effect of enoxacin on colonie microflora of healthy volunteers. Eur J Clin Microbiol 1987; 6: 298-300
12. Meckenstock R, Haralambie E, Linzenmeier G, et al. Die Beeinflussung der Darmflora durch Norfloxacin bei gesunden Menschen. Z Antimikr Antineoplast Chemother 1985; 1: 27-34
13. De Vries-Hospers HG, Welling GW, van der Waaij D. Norfloxacin for selective decontamination. A study in human volunteers. Prog Clin Biol Res 1985; 181: 259-62
14. Leigh DA, Emmanuel FXS, Tighe C, et al. Pharmacokinetic studies of norfloxacin in healthy volunteers and effect on the faecal flora. Proceedings of the 14th International Congress of Chemotherapy; 1985 Jun 23-28; Kyoto, Japan: 1835-6
15. Pecquet S, Andremont A, Tancrede C. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with human fecal flora. Antimicrob Agents Chemother 1986; 29: 1047-52
16. Edlund C, Bergan T, Josefsson K, et al. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis 1987; 19: 113-21
17. Pecquet S, Andremont A, Tancrede C. Effect of ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother 1987; 31: 124-5
18. Edlund C, Kager L, Malmborg AS, et al. Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol Infect Dis 1988; 7: 135-43
19. Edlund C, Sjostedt S, Nord CE. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand J Infect Dis 1997; 29: 383-6
20. Vollaard EJ, Clasener HAL, Janssen AJHM. Influence of pefloxacin on microbial colonization resistance in healthy volunteers. Eur J Clin Microbiol Infect Dis 1992; 11: 257-60
21. Edlund C, Brismar B, Nord CE. Effect of lomefloxacin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis 1990; 9: 35-9
22. Ritz M, Lode H, Fassbender M, et al. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother 1994; 38: 455-9
23. D'Antonio D, Pizzigallo E, Iacone A, et al. The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. J Antimicrob Chemother 1996 38: 839-47
24. Inagaki Y, Yamamoto N. The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers. Jpn J Antibiot 1995; 3: 368-79
25. Edlund C, Nord CE. Ecological effect of gatifloxacin on the normal human intestinal microflora. J Chemother 1999; 11: 50-3
26. van Nispen C, Hoepelman A, Rozenberg-Arska M, et al. A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers. Am J Surg 1998; 176 Suppl. 6A: 27S-31S
27. Hiemer-Bau M, Beyere G, Stass H, et al. Pharmacokinetics and influence of moxifloxacin on bacterial intestinal flora in young male subjects [abstract A-016]. Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1998 Sep 24-27; San Diego. Washington DC: American Society for Microbiology, 1998